Meanwhile, the risk ratio of CEP55 overexpression was HR = 1.76 (CI: 1.22–2.55) (Figure 3H), revealing that CEP55 may be a promising predictor of the prognosis of patients with gallbladder cancer. This evidence concerns the gene CEP55 and gallbladder cancer.